Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

sk for relapse of this devastating blood disorder."

The study showed that extremely low levels of ADAMTS13 activity are associated with increased risk of TTP relapses during remission. A key characteristic of the assay is that it is more sensitive than other assays and exhibits improved accuracy at low (<2.5 percent) ADAMTS13 activity.

"These study findings represent an important milestone, as they demonstrate that the test -- which our Company co-developed with the OSU Research Foundation -- could be utilized not only for diagnosing TTP, but also for surveillance of TTP patients during clinical remission," said Gail Page, President and CEO of Vermillion. "Vermillion is dedicated to the development and commercialization of molecular diagnostic tests to help physicians and their patients diagnose and appropriately treat diseases, particularly cardiovascular disease and cancer. The TTP test is an example of how our technology has led to significant new means to properly diagnose and screen patients with this serious disorder."

Using the SELDI-TOF technology, the TTP test could help physicians make the correct diagnosis, initiate timely treatment, and evaluate response to therapy. These new study findings suggest that the test can additionally be used to help screen for the risk of relapse in patients with TTP.

About the Study

ADAMTS13 activity and ADAMTS13 antibody (IgG) were evaluated in 157 clinical samples collected prospectively during periods of clinical remission from 24 TTP patients enrolled in other prospective studies at OSU. These patients received regular follow-up for an average of 23 months, with serial samples taken at 3-month intervals. Nine episodes of TTP relapse occurred among six patients. Logistic regression modeling was used to define the relationship between ADAMTS13 activity levels and the probability of TTP relapses.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... EAST HANOVER, N.J. , April 24, 2015  Novartis ... diversity for the second year in a row on the ... the results of its 2015 Top 50 Companies for Diversity ... New York, NY . NPC also ranked second on ... on the Top 10 Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... Hi-Tech Pharmaceuticals refutes the results from ... of reliable scientific principles and methods and therefore ... of adulteration. The FDA is resting its very, ... misguided hope, that Methylphenylethylamine is not found in ... multiple other studies and cannot be relied on ...
(Date:4/24/2015)... 24, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" ... premium quality medical marijuana products and a licensed producer ... Purposes Regulations ( Canada ) ("MMPR"), is ... its shareholders, has closed the transaction announced on March ... acquired (the "Escrow Transfer") a total of 20,156,790 common ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... YORK, Oct. 5 Reportlinker.com announces that a ... catalogue: Nanobiotechnologies- applications, markets and ... SummaryNanotechnology is the creation and ... control of matter on the nanometer-length scale (a ...
... The Thompson Group of Companies announced today that it ... Hamilton Sundstrand Corporation business. AIT will be organized as ... of the purchase were not disclosed. AIT ... of process analytical instruments including Analect FTIR, PIONIR Near-Infrared, ...
Cached Medicine Technology:Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 21Thompson Group Acquires Hamilton Sundstrand's Applied Instrument Technologies 2
(Date:4/24/2015)... Lowcostcarinsuranceprice.com has released a new blog ... insurance for senior citizens . , Senior citizens ... not mean that they cannot find affordable coverage. By ... find the right coverage for their cars at the ... http://lowcostcarinsuranceprice.com/ provides free leads from various agencies ...
(Date:4/24/2015)... BC (PRWEB) April 24, 2015 Olive ... Yuzpe, Olive Fertility co-founder and co-director, has been honoured ... Preservation at the Evening of Hope Gala. , ... recognize Dr. Albert Yuzpe, who has been at the ... 43 years,” says Jessica Séguin, Executive Director of Fertile ...
(Date:4/24/2015)... 2015 National Access Cannabis ... access to medical cannabis, is taking a leadership role ... advising patients. , NAC is the first to back ... $250,000 grant, NAC will be providing 300 healthcare professionals ... is to help Canadians gain safe and responsible access ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data event ... suppliers, content providers, associations and government bodies. From industry ... see them converge in Berlin. This year’s start-up competition ... companies currently at the forefront of Europe’s Silicon Valley ... centric products, ParkTAG are one of the first social ...
(Date:4/24/2015)... 2015 PURE Solutions, a leader in ... Network (The Network), a highly respected education, advocacy and ... tips and information for a special allergy ... , The goal for both organizations is to “make ... of people with asthma and allergies and by finding ...
Breaking Medicine News(10 mins):Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:PURE Solutions Partners with Allergy and Asthma Network to Provide Allergy Travel Tips 2
... ... Higher Value Products, PHOENIX, Feb. 4 NutraCea ... nutrient research and,technology, announced today that it has executed a definitive ... America,located in Brazil. This transaction is expected to close prior to ...
... SAP Public Services, Inc.,a subsidiary of SAP AG ... as vice,president of its U.S. healthcare practice. The ... and,government-driven initiatives to improve the quality and delivery ... responsible for growing,SAP,s business in the U.S. healthcare ...
... Stage of Growth and Development, RESTON, Va., ... Mirixa,Corporation announced today that Donald W. Hackett, chief ... the company, effective,immediately., Bruce Roberts, RPh, executive ... Association (NCPA) and chairman of Mirixa,s board of,directors, ...
... Inhaled Corticosteroid approved for ... Young as Age 4, KENILWORTH, N.J., Feb. 4 ... Food and Drug,Administration (FDA) has approved ASMANEX (R) TWISTHALER (R) ... as a preventive therapy in patients 4 to 11 years ...
... 4 (OTC Pinksheets: HRAL) -,HearAtLast Holdings, Inc. ... another,license from Wal-Mart Canada (NYSE: WMT ) ... co-located within Wal-Mart Store #5778 located at 135,First ... is scheduled,for Tuesday, February the 5th, 2008. The ...
... Increase Awareness, Education about Bone Disease, ... about the bone-weakening disease osteoporosis, the Pennsylvania,Commission ... Dairy Association,and Pennsylvania Dairy Promotion Program to ... Bedford, Cameron, Clinton, Juniata,Perry, Sullivan, and Tioga ...
Cached Medicine News:Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 2Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 3Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 4Health News:SAP Names David Corbett as Vice President of U.S. Healthcare Practice 2Health News:SAP Names David Corbett as Vice President of U.S. Healthcare Practice 3Health News:SAP Names David Corbett as Vice President of U.S. Healthcare Practice 4Health News:SAP Names David Corbett as Vice President of U.S. Healthcare Practice 5Health News:Mirixa Corporation Announces Leadership Change 2Health News:FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 2Health News:FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 3Health News:FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 4Health News:FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 5Health News:FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11 6Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 2Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 3Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 4Health News:PA Commission for Women Announces 'Shocking Pink' Osteoporosis Campaign in Rural PA 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: